Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
- 2 April 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 125 (3), 687-696
- https://doi.org/10.1007/s10549-010-0855-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Gene-Expression Signatures in Breast CancerNew England Journal of Medicine, 2009
- Triple negative tumours: a critical reviewHistopathology, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survivalBreast Cancer Research, 2007
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survivalProceedings of the National Academy of Sciences of the United States of America, 2005
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Molecular portraits of human breast tumoursNature, 2000
- Tumor progression and metastasisCarcinogenesis: Integrative Cancer Research, 2000
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986